Header Logo

Connection

MICHAEL JOHNSON to United States

Back to Details
This is a "connection" page, showing publications MICHAEL JOHNSON has written about United States.
MICHAEL JOHNSON
Connection Strength
1.299
United States
  1. Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071.
    View in: PubMed
    Score: 0.082
  2. Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study. Cancer. 2023 04 01; 129(7):1051-1063.
    View in: PubMed
    Score: 0.073
  3. Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2- metastatic breast cancer in the United States. Breast Cancer Res Treat. 2023 Feb; 198(1):159-166.
    View in: PubMed
    Score: 0.073
  4. Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States. J Pharm Pract. 2024 Feb; 37(1):123-131.
    View in: PubMed
    Score: 0.072
  5. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes. Breast Cancer Res Treat. 2022 Oct; 195(3):421-430.
    View in: PubMed
    Score: 0.071
  6. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer. 2019 04 01; 125(7):1155-1162.
    View in: PubMed
    Score: 0.055
  7. Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States. Res Social Adm Pharm. 2013 Jan-Feb; 9(1):13-26.
    View in: PubMed
    Score: 0.035
  8. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012 Sep; 8(5):437-44.
    View in: PubMed
    Score: 0.035
  9. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
    View in: PubMed
    Score: 0.033
  10. Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis. Res Social Adm Pharm. 2012 Mar-Apr; 8(2):145-56.
    View in: PubMed
    Score: 0.032
  11. Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry. 2011 Jul; 26(7):749-57.
    View in: PubMed
    Score: 0.031
  12. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health. 2009 Nov-Dec; 12(8):1044-52.
    View in: PubMed
    Score: 0.029
  13. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II. Value Health. 2009 Nov-Dec; 12(8):1053-61.
    View in: PubMed
    Score: 0.029
  14. The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Ann Pharmacother. 2009 Oct; 43(10):1565-75.
    View in: PubMed
    Score: 0.029
  15. VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care. 2009 Mar 16; 15(3):e1-8.
    View in: PubMed
    Score: 0.028
  16. Patterns of antihypertensive therapy among patients with diabetes. J Gen Intern Med. 2005 Sep; 20(9):842-6.
    View in: PubMed
    Score: 0.022
  17. Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research compliance. IRB. 2005 Mar-Apr; 27(2):6-10.
    View in: PubMed
    Score: 0.021
  18. Prescribing patterns of diuretics in multi-drug antihypertensive regimens. J Clin Hypertens (Greenwich). 2005 Feb; 7(2):81-7; quiz 88-9.
    View in: PubMed
    Score: 0.021
  19. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am J Manag Care. 2004 Dec; 10(12):926-32.
    View in: PubMed
    Score: 0.021
  20. Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
    View in: PubMed
    Score: 0.019
  21. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
    View in: PubMed
    Score: 0.018
  22. Risk assessment and adjustment: adjusting for sick patients or a sick system? Med Care. 2003 Jan; 41(1):4-7.
    View in: PubMed
    Score: 0.018
  23. Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling. Pharmacotherapy. 2022 07; 42(7):518-528.
    View in: PubMed
    Score: 0.017
  24. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs Aging. 2022 06; 39(6):453-465.
    View in: PubMed
    Score: 0.017
  25. Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1351-1358.
    View in: PubMed
    Score: 0.017
  26. Effect of definition of mortality on hospital profiles. Med Care. 2002 Jan; 40(1):7-16.
    View in: PubMed
    Score: 0.017
  27. Risk of overactive bladder associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc. 2022 03; 70(3):820-830.
    View in: PubMed
    Score: 0.017
  28. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study. Curr Med Res Opin. 2021 08; 37(8):1303-1313.
    View in: PubMed
    Score: 0.016
  29. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs Aging. 2021 06; 38(6):493-502.
    View in: PubMed
    Score: 0.016
  30. Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use. JAMA Netw Open. 2020 04 01; 3(4):e203821.
    View in: PubMed
    Score: 0.015
  31. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease. Am J Geriatr Psychiatry. 2020 10; 28(10):1079-1088.
    View in: PubMed
    Score: 0.015
  32. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. J Gen Intern Med. 2020 07; 35(7):2084-2093.
    View in: PubMed
    Score: 0.015
  33. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
    View in: PubMed
    Score: 0.015
  34. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease. J Psychiatr Res. 2019 10; 117:116-121.
    View in: PubMed
    Score: 0.014
  35. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Res Social Adm Pharm. 2020 03; 16(3):329-335.
    View in: PubMed
    Score: 0.014
  36. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders. J Manag Care Spec Pharm. 2019 Jan; 25(1):29-38.
    View in: PubMed
    Score: 0.014
  37. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. BMC Health Serv Res. 2018 04 02; 18(1):236.
    View in: PubMed
    Score: 0.013
  38. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. Drugs Aging. 2017 09; 34(9):691-700.
    View in: PubMed
    Score: 0.013
  39. The Prevalence of and Factors Associated With Receiving Concurrent Controlled Substance Prescriptions. Subst Use Misuse. 2017 Oct 15; 52(12):1639-1645.
    View in: PubMed
    Score: 0.012
  40. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine. Pharmacotherapy. 2017 03; 37(3):287-296.
    View in: PubMed
    Score: 0.012
  41. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression. J Am Geriatr Soc. 2016 07; 64(7):1492-7.
    View in: PubMed
    Score: 0.012
  42. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression. Am J Geriatr Psychiatry. 2016 06; 24(6):485-95.
    View in: PubMed
    Score: 0.011
  43. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study. J Am Geriatr Soc. 2016 Feb; 64(2):394-400.
    View in: PubMed
    Score: 0.011
  44. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105.
    View in: PubMed
    Score: 0.011
  45. Potentially inappropriate anticholinergic medication use in older adults with dementia. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):603-612.
    View in: PubMed
    Score: 0.011
  46. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors. Psychiatr Serv. 2015 Dec 01; 66(12):1333-40.
    View in: PubMed
    Score: 0.011
  47. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study. Drugs Aging. 2015 May; 32(5):379-89.
    View in: PubMed
    Score: 0.011
  48. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. Am J Clin Oncol. 2015 Apr; 38(2):165-73.
    View in: PubMed
    Score: 0.011
  49. Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid. Psychiatr Serv. 2015 Apr 01; 66(4):404-10.
    View in: PubMed
    Score: 0.010
  50. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32.
    View in: PubMed
    Score: 0.008
  51. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics. 2009 Nov-Dec; 50(6):592-8.
    View in: PubMed
    Score: 0.007
  52. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother. 2008 Oct; 6(4):198-204.
    View in: PubMed
    Score: 0.007
  53. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. Curr Med Res Opin. 2008 Mar; 24(3):709-16.
    View in: PubMed
    Score: 0.006
  54. Antipsychotic utilization and expenditure trends among elderly persons. Psychiatr Serv. 2007 Nov; 58(11):1400.
    View in: PubMed
    Score: 0.006
  55. Performance of endovascular aortic aneurysm repair in high-risk patients: results from the Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2007 Feb; 45(2):227-233; discussion 233-5.
    View in: PubMed
    Score: 0.006
  56. Open versus endovascular abdominal aortic aneurysm repair in VA hospitals. J Am Coll Surg. 2006 Apr; 202(4):577-87.
    View in: PubMed
    Score: 0.006
  57. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005 Oct; 129(4):1171-8.
    View in: PubMed
    Score: 0.006
  58. Process of care in Hispanic, black, and white VA beneficiaries. Med Care. 2002 Sep; 40(9):824-33.
    View in: PubMed
    Score: 0.004
  59. Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care. 2002 Jan; 40(1 Suppl):I106-16.
    View in: PubMed
    Score: 0.004
  60. Preoperative risk factors for 30-day mortality after elective surgery for vascular disease in Department of Veterans Affairs hospitals: is race important? J Vasc Surg. 2001 Oct; 34(4):634-40.
    View in: PubMed
    Score: 0.004
  61. An empirical assessment of the validity of explicit and implicit process-of-care criteria for quality assessment. Med Care. 1999 Aug; 37(8):798-808.
    View in: PubMed
    Score: 0.004
  62. International Classification of Diseases, 9th Revision, Clinical Modification codes in discharge abstracts are poor measures of complication occurrence in medical inpatients. Med Care. 1997 Jun; 35(6):589-602.
    View in: PubMed
    Score: 0.003
  63. Identifying complications and low provider adherence to normative practices using administrative data. Health Serv Res. 1995 Oct; 30(4):531-54.
    View in: PubMed
    Score: 0.003
  64. Expected source of payment and use of hospital services for coronary atherosclerosis. Med Care. 1995 Jul; 33(7):715-28.
    View in: PubMed
    Score: 0.003
  65. In-hospital complications among survivors of admission for congestive heart failure, chronic obstructive pulmonary disease, or diabetes mellitus. J Gen Intern Med. 1995 Jun; 10(6):307-14.
    View in: PubMed
    Score: 0.003
  66. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995 Mar 15; 122(6):415-21.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.